Major GlobalCardio™ Sale to Biomedical Systems Inc. Announced

Victoria, BC, Aug 27, 2002 CardioComm Solutions Inc. (TSXV:CCG) (the "Company", "CardioComm"), is pleased to announce that it has signed an extensive sale and cross-distribution agreement with U.S. based Biomedical Systems Inc. ("Biomedical"). The agreement includes the sale of a customized version of GlobalCardio(TM) that will be utilized by the pharmaceutical and clinical services divisions of Biomedical Systems. They will host this web application from their facility in St. Louis, Missouri, as they have the infrastructure (telecommunications, redundant power systems, secure server storage) to accommodate the web-hosting.

The agreement also allows for Biomedical to be a non-exclusive distributor of CardioComm's GEMS and GlobalCardio(TM) products in the U.S. market. This agreement marks the third distribution agreement for CardioComm in the last four months."This agreement marks the largest sale in CardioComm history. We are very excited about all aspects of this new relationship, especially the first major sale of our web-based technology. Biomedical is the first to use GlobalCardio(TM) and its web based applications for event monitoring and pacemaker follow-up service business," said Stephen Martin, CEO of CardioComm. "This innovative approach to the U.S. service marketplace will surely give Biomedical a competitive advantage providing their customer base with direct information access to their patients' ECGs from any location via the web."

David Bondietti, Senior Vice President of Marketing and Business Development of Biomedical Systems, remarked "As a medical service provider, getting timely ECG information into the hands of our customers is a vital part of our business. We believe that our implementation of the GlobalCardio(TM) system along with our web-based Holter data exchange network, will allow us to provide instant access to ECG information to our customers at any time and from any location where a web browser is available."

About Biomedical Systems Inc.
Biomedical Systems Corporation is a global medical company dedicated to improving health around the world through its Perinatal, Pharmaceutical, Cardiology Systems, Cardiology Services and Wound Care Products divisions. The company was founded in 1975 and has headquarters in St. Louis and operates in 58 countries. World headquarters are in St. Louis, Missouri. European headquarters are in Brussels, Belgium.

Additional information on Biomedical Systems can be found at: www.biomedsys.com.

About CardioComm Solutions Inc:
CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has both ISO 9001 and EN 46001 certifications.

On behalf of the Board of Directors of CardioComm Solutions Inc.:

“Stephen Martin”

Stephen R. Martin, President & CEO

For investor information, please contact:

Stephen Martin
1-877-744-1122